PPARγ is expected to provide a new therapeutic approach for the treatment of atherosclerotic and ischemic cerebrovascular diseases, and it is essential for the prevention of neurodegenerative diseases, including AD [39]. The gene discussed is PPARG; the disease is Alzheimer disease.